Index - Tres Cantos Open Lab Foundation

TCOLF engages with public and private Research Institutes, High Education Institutions and Companies that work in the research areas supported and that share its principles. The Foundation supports collaborative projects between one of these organizations (the “Home Institution”), and GSK R&D Spain (the “Host Institution”).

Portfolio of complete and ongoing projects Open Lab scientists work at the Tres Cantos campus during part or the whole project duration, accessing GSK drug discovery expertise as part of an integrated team to develop new medicines for endemic infectious diseases.

Home Institutions supported to date include:

Learn about pioneering projects that have successfully secured the Foundation’s support.

Discover how the Foundation is supporting innovation in drug discovery and find out more about the ground-breaking projects that are benefiting from collaboration, GSK’s expertise, and the resources at the Tres Cantos Global Health R&D site.

America

University of Washington

University of Alabama at Birmingham

University of South Florida (USF)

Seattle Children’s Research Institute & University of Washington

University of Washington

University of California

IBR-CONICET_UNR Instituto de Biología Molecular y Celular de Rosario

University of Michigan

University of Georgia

California Institute for Biomedical Research

Caucaseco Scientific Research Center and Malaria Vaccine and Drug Development Center

Joan & Sanford Weill Medical College of Cornell University

Harvard Medical School

CIDR / Seattle Biomed Research Institute

The University of British Columbia

Weill Cornell Medical College

Harvard School of Public Health and Broad Institute

University of Glasgow (UoG), Marine Biological Laboratory (MBL) and Northeastern University (NEU)

SUNY Upstate Medical University

University of British Columbia

Center for Tropical and Emerging Global Diseases, University of Georgia

Weill Cornell Medical College

University of Minnesota

Seattle Biomedical Research Institute

New York University, School of Medicine

University of Durham

Northeastern University, USA and CSIC, Spain

Florida International Univ

CNRS / Institut de Biologie Structurale and Harvard Medical School

University of British Columbia

IQUIBICEN-CONICET

Europa

London School of Hygiene and Tropical Medicine

Structural Genomics Consortium

Sanger Institute

University of Zaragoza

University of Cambridge

Research Agency of Aragon (ARAID) & University of Zaragoza (UNIZAR)

EMBL- Unravelling new combinatorial therapies against Shigellosis)

University of Georgia + Bioaster

Oxford University

Oxford University Clinical Research Unit

Biomedical Primate Research Centre

Utrecht University

University of Dundee

Martin Luther University of Halle

Universidad San Pablo CEU and University of Glasgow

Medical Research Council

University of Glasgow (UoG), Marine Biological Laboratory (MBL) and Northeastern University (NEU)

TeagueMedChem

University Of Helsinki

London School of Hygiene & Tropical Medicine-LSHTM

University of Liverpool

University of Rome

Omnia Molecular

Northeastern University, USA and CSIC, Spain

CRESIB, Spain

CICBIOGUNE, Spain

Birmingham University

NEU/CSIC

University of Birmingham

McGill Univ/Edinburgh Univ

CNRS / Institut de Biologie Structurale and Harvard Medical School

University of Birmingham - Exploring TB Space

University of Birmingham

University of Birmingham - ChemPro_Target_ID

London School of Hygiene and Tropical Medicine (LSHTM)

“Severo Ochoa” Molecular Biology Center and University of León

London School of Hygiene and Tropical Medicine

National Institute of Blood Transfusion & INSERM

Asia

Mahidol University

Institute Pasteur Korea

Oceanía

University of Melbourne

Monash University

University of Sydney

Our Partnerships

The partnership between GSK and TCOLF is committed to research new treatments for diseases that affect millions of people in the world’s developing nations. To facilitate the establishment of the Tres Cantos Open Lab Foundation, GSK provided £10 million of an initial investment to support the Foundation’s objectives. In 2018 an additional £5m in GSK funding to support the Foundation’s research and development programmes in endemic infectious diseases was announced.

The TCOLF is open to new partnership opportunities. Organizations interested, please contact Openlab Foundation.

Research projects

America

Europa

Asia

Oceanía